ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER

Dhivya R Sudhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.